<DOC>
	<DOCNO>NCT01538134</DOCNO>
	<brief_summary>The Antiphospholipid Syndrome immune disease presence antibody direct cell membrane phospholipid ( antiphospholipid antibody ) cause hypercoagulable state cause thrombosis obstetric complication ( miscarriage , stillbirth ) . Since 1999 Sapporo Criteria Antiphospholipid Syndrome diagnosis include development fetal growth restriction ( diagnosed postpartum ) , do without solid evidence relation two use common form fetal growth restriction diagnosis ( ultrasound ) . Our study try add information particular point .</brief_summary>
	<brief_title>Antiphospholipid Antibodies Fetal Growth Restriction</brief_title>
	<detailed_description />
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<criteria>Gestational age 2434 week . Ultrasonographic evidence fetal growth restriction Abdominal circumference &lt; 3rd percentile . Doppler increase placental resistance . Known antiphospholipid syndrome . Known presence antiphospholipid antibody . Patients systemic lupus erythematosus .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Antibodies , anticardiolipin</keyword>
	<keyword>Antibodies , B2 Glycoprotein I</keyword>
	<keyword>Lupus Anticoagulant</keyword>
	<keyword>Fetal Growth Restriction</keyword>
</DOC>